NO
Neogenix Oncology Inc Stock: price and insider trades · United States
Neogenix Oncology Inc: what insiders have been doing
Only a handful of insider records exist for Neogenix Oncology Inc, the last one from 13 February 2013, too few to describe a trend. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2011FY ended December 2011 · cache
Income statement
Net income-17.1M
Last declaration on 13 February 2013
Declarations3 total
- 3,470,000 shares0Common StockSEC:0001144204-13-008317:0
- 325,000 shares0Common StockSEC:0001144204-13-008299:0
- 220,000 shares0Common StockSEC:0001144204-13-008298:0
3 of 3 declarations
About Neogenix Oncology Inc
Neogenix Oncology Inc is a company focused on developing diagnostic solutions for cancer. It aims to enhance oncology treatments through innovative technologies.
